The largest database of trusted experimental protocols

Cell proliferation assay system

Manufactured by Takara Bio
Sourced in Japan, Sweden

The Cell Proliferation Assay System is a tool designed to measure and analyze the growth and proliferation of cells in a laboratory setting. It provides quantitative data on cell population dynamics, enabling researchers to study various cellular processes and responses.

Automatically generated - may contain errors

5 protocols using cell proliferation assay system

1

Adhesion Potential of MDA-MB-231 Breast Cancer Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
In order to evaluate the adhesion potential of MDA-MB-231 breast cancer cells, the following adhesion protocol was conducted, as it was described by previous works [39 (link),40 (link)]. Briefly, 96-well plate was coated with collagen type I solution (40 μg/mL) and kept at 4 °C. After 12 h, the solution was removed, and the plate was air-dried; 3% BSA in PBS solution was added in each well, for 30 min, to block non-specific adsorption. Then the solution was removed, and the plate was washed with PBS and air-dried. Cells treated for 24 h prior to the adhesion assay were detached with PBS-EDTA 1× and resuspended in serum-free medium with 0.1% BSA. and seeded at a density of 2 × 104 cells/well. Cells were incubated for 30 min, to allow adhesion to the surface. Non-adherent cells were removed with serum free medium, and then cells were incubated with medium supplemented with 10% FBS for 2–3 h for recovery. After the incubation period, Premix WST-1 (water-soluble tetra-zolium salt) Cell Proliferation Assay System (Takara Bio Inc., Göteborg, Sweden) was added at a ratio 1:10, and the absorbance at 450 nm was measured (reference wavelength at 650 nm).
+ Open protocol
+ Expand
2

Cell Proliferation Assay with WST-1

Check if the same lab product or an alternative is used in the 5 most similar protocols
Parental and transfected breast cancer cells were seeded in the presence of FBS into 96-well plates at a density of 5,000 cells/well and then the cells were incubated in serum-free culture medium. Premix WST-1 (water-soluble tetrazolium salt) Cell Proliferation Assay System (Takara Bio Inc., Japan) was added after 24 hours at a ratio 1:10. The assay is based on the reduction of WST-1 by viable cells, producing a soluble formazan salt absorbing at 450 nm (reference wavelength at 650 nm).
+ Open protocol
+ Expand
3

Collagen-Induced Proliferation of MSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Wharton’s jelly MSCs and DPSCs at passage five were seeded in 48-well plates containing type II collagen at a density of 3,200 cells/well and then the cells were incubated in DMEM supplemented with 2% FBS for 3, 7, 10, 14 and 24 days. Medium was replaced every two days following one wash with PBS 1X. Premix WST-1 (water-soluble tetrazolium salt) Cell Proliferation Assay System (Takara Bio Inc., Japan) was added after the treatment period at a ratio 1:10 for 1-3 h depending on cell density. The assay is based on the reduction of WST-1 by viable cells, producing a soluble formazan salt absorbing at 450 nm (reference wavelength at 650 nm). Following incubation, the optical density of each well was measured at 450 nm with a TECAN spectrophotometer.
+ Open protocol
+ Expand
4

Breast Cancer Cell Adhesion Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
In order to evaluate the adhesion potential of breast cancer cells, the following adhesion protocol was performed, as previously described (25 (link)). Briefly, 96-well plate was coated with collagen type I (40 μg/ml) and kept at 4°C. After 12 hours, the solution was removed, and the plate was air-dried; 3% BSA in PBS solution was added in each well, for 30 minutes, to block non-specific adsorption. Then the solution was removed, and the plate was washed with PBS and air-dried. Cells treated for 24 hours prior to the adhesion assay were detached with PBS-EDTA 1x and resuspended in serum-free medium with 0.1% BSA. and seeded at a density of 2x104 cells/well. Cells were incubated for 30 min, to allow adhesion to the surface. Non-adherent cells were removed with serum free medium, and then cells were incubated with medium supplemented with 10% FBS for 2 hours for recovery. Premix WST-1 (water-soluble tetra-zolium salt) Cell Proliferation Assay System (Takara Bio Inc., Göteborg, Sweden) was then added at a ratio 1:10, and the absorbance at 450 nm was measured (reference wavelength at 650 nm).
+ Open protocol
+ Expand
5

Evaluating Liposomes for Cancer Treatment

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following reagents were used in this study: gefitinib (Cell Signaling Technology, Inc., Danvers, MA, USA), human epidermal growth factor (EGF), penicillin-streptomycin, FITC-dextran (70 kDa) (Sigma-Aldrich Co., Inc., St. Louis, MO, USA), FITC-transferrin (Rockland Immunochemicals Inc., Limerick, PA, USA), RPMI-1640, minimum essential medium-α (α-MEM), fetal bovine serum (FBS) (Gibco, Life Technologies Corporation, Grand Island, NY, USA), exosome-free FBS (EXO-FBS, ATLAS Biological, Fort Collins, CO, USA), Dulbecco’s phosphate-buffered saline (PBS) and trypsin (0.5 g/L)/ethylenediaminetetraacetic acid (EDTA) (0.53 mmol/L) solution with phenol red (Nacalai Tesquen Inc., Kyoto, Japan), Hoechst 33342 (Invitrogen, Austin, TX, USA), dimethyl sulfoxide (DMSO), doxorubicin (Wako Pure Chemical Co., Inc., Osaka, Japan), the Pierce BCA Protein Assay Kit (Thermo Fisher Scientific Inc., Rockford, IL, USA), the Premix WST-1(4-[3-(4-iodophenyl)-2-(4-nitrophenyl)-2H-5-tetrazolio]-1,3-benzene disulfonate) Cell Proliferation Assay System (Takara Bio Inc., Shiga, Japan), FITC-labeled liposomes (DOPC:CHOL:FITC-DHPE at a molar ratio of 54:45:1), doxorubicin-loaded liposomes (HSPC:CHOL:mPEG2000-DSPE at a molar ratio of 56.2:38.5:5.3) (FormuMax Scientific Inc., Sunnyvale, CA, USA), SDS-PAGE gel plates (Bio Craft Co., Tokyo, Japan), and silver stain reagent (Cosmo Bio Co., Tokyo, Japan).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!